DIAGNOSTIC AND THERAPEUTIC BENEFITS OF ORAL GASTROGRAFIN IN ADHESIVE INTESTINAL OBSTRUCTION | ||||
| The Egyptian Journal of Surgery | ||||
| Article 4, Volume 30, Issue 2, April 2011, Page 62-68 PDF (796.01 K) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/ejsur.2011.367372 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| Ramadan El Lithy1; Mosaad Morshed2; Jasmi Yaakub2; Emad El Din Abdallah* 2; Mohamed Farid2 | ||||
| 1General Surgery Department, Mansoura University, Egypt | ||||
| 2General Surgery Department, Mansoura University, Egypt. | ||||
| Abstract | ||||
| Aim: Assessment of the diagnostic and therapeutic effects of gastrografin in adhesive intestinal obstruction (AIO). Methods: Eighty patients with AIO were randomized into control and gastrografin groups. In the gastrografin group, 100mL of the dye was administered through a nasogastric tube. Obstruction was considered complete if the contrast failed to reach the colon on the 24hours X ray film and surgery was done. If contrast reached the colon on 24 hours obstruction was considered partial where conservative treatment was continued. Results: The overall operative rate was 15% in gastrografin group versus 35% in control group, P= 0.039. The time from admission to resolution of symptoms was significantly lower in gastrografin group (23.2 vs.32.1hours; P= 0.004), and the length of hospital stay was shorter in gastrografin group (3.5 vs.4.3days; P = 0.003). Sensitivity, specificity, positive predictive value, and negative predictive value for gastrografin follow-through as an indicator for operative treatment of adhesive intestinal obstruction were 83%, 100%, 100%, and 97%, respectively. Conclusions: Oral gastrografin is safe and reduces the operative rate and time of resolution as well as hospital stay. | ||||
| Keywords | ||||
| Oral contrast; Adhesiolysis; Small bowel | ||||
|
Statistics Article View: 61 PDF Download: 35 |
||||
